Aslan pharmaceuticals limited

Major-Pharmaceuticals

ASLN


83 Clemenceau Avenue
Singapore , 239920

Executive/
Director

Price

  • Last Close
  • $ 0.57
    $ -0.1 -14.29 %
    Mar 10, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 610,341
  • Market Cap Full
  • $ 229.2M
  • Shares Outstanding
  • 402.1M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - 19.2% -5% 81.1% -19.6% 58.3% - -
Q2 - - 58.7% -24% 4% -1.5% -45% - - -
Q3 - - -5.1% -46.6% 8% -46.1% 21% - - -
Q4 - - -55% 17% -0.5% -37.1% -39.9% - - -
J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 - - - - - - - - - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%-44%-8%-39%-68%58%0%0%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - -0.34 -0.13 -0.1 -0.13 -0.95 -1.29
Q2 - - -0.37 -0.25 -0.1 - -1.75 -0.11
Q3 - - -0.35 - -0.1 -0.12 -0.8 -0.56
Q4 - - -0.34 -0.9 -0.12 -0.15 -0.18 -
A 0 0 -1.4 -1.3 -0.4 -0.4 -3.68 -1.96

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 160.2 190 237.7 402.1 402.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover - - - - -
Total Asset Turnover - - - 0.1 -
Leverage
Debt Ratio 0.5 0.3 0.9 0.8 0.5
Debt – Equity Ratio 3.8 0.5 -1.5 -18 0.5
Interest Coverage -16 11.3 - -46 -
Equity multiplier - - - - -